| 763 |
increased |
viral translation
(GO:0019081)
|
ssRNA viral genome
(GO:0019024)
|
1847: Increased SARS-CoV-2 production
|
| 764 |
increased |
cellular response to oxidative stress
(GO:0034599)
|
reactive oxygen species
(CHEBI:26523)
|
1869: Diminished protective oxidative stress response
|
| 765 |
increased |
response to reactive oxygen species
(GO:0000302)
|
reactive oxygen species
(CHEBI:26523)
|
2 Events
|
| 767 |
increased |
endocytosis involved in viral entry into host cell
(GO:0075509)
|
|
None
|
| 768 |
increased |
protease binding
(GO:0002020)
|
|
None
|
| 769 |
increased |
neuropilin binding
(GO:0038191)
|
|
None
|
| 774 |
increased |
|
deoxyribonucleic acid
(CHEBI:16991)
|
1879: Bulky DNA adducts, increase
|
| 780 |
increased |
negative regulation of fibrinolysis
(GO:0051918)
|
|
1866: Fibrinolysis, decreased
|
| 782 |
increased |
increased vascular permeability
(MP:0003070)
|
|
1867: Bradykinin system, hyperactivated
|
| 783 |
increased |
vasodilation
(GO:0042311)
|
|
1867: Bradykinin system, hyperactivated
|
| 784 |
increased |
vascular inflammation
(MP:0001863)
|
|
1867: Bradykinin system, hyperactivated
|
| 797 |
increased |
oxidative phosphorylation uncoupler activity
(GO:0017077)
|
mitochondrion
(GO:0005739)
|
1446: Decrease, Coupling of oxidative phosphorylation
|
| 799 |
increased |
proton binding
(GO:1901691)
|
mitochondrion
(GO:0005739)
|
1446: Decrease, Coupling of oxidative phosphorylation
|
| 804 |
increased |
translation
(GO:0006412)
|
mucin-5AC
(PR:000031343)
|
962: Increase, Mucin production
|
| 805 |
increased |
mucus secretion
(GO:0070254)
|
lung goblet cell
(CL:1000143)
|
1251: Chronic, Mucus hypersecretion
|
| 806 |
increased |
NLRP3 inflammasome complex assembly
(GO:0044546)
|
NLRP3 inflammasome complex
(GO:0072559)
|
1895: NLRP3 inflammasome activity, increased
|
| 811 |
increased |
glycosylation
(GO:0070085)
|
mucin-5AC
(PR:000031343)
|
1910: Mucus Viscosity, Increased
|
| 812 |
increased |
mRNA transcription
(GO:0009299)
|
angiotensin-converting enzyme 2 (human)
(PR:Q9BYF1)
|
None
|
| 813 |
increased |
regulation of peptidase activity
(GO:0052547)
|
angiotensin-converting enzyme (human)
(PR:P12821)
|
None
|
| 815 |
increased |
mRNA transcription
(GO:0009299)
|
angiotensin-converting enzyme 2
(PR:000003622)
|
1854: Dysregulation, ACE2 expression and activity
|
| 816 |
increased |
carboxypeptidase activity
(GO:0004180)
|
angiotensin-converting enzyme 2
(PR:000003622)
|
1854: Dysregulation, ACE2 expression and activity
|
| 818 |
increased |
|
angiotensin-converting enzyme 2
(PR:000003622)
|
1854: Dysregulation, ACE2 expression and activity
|
| 819 |
increased |
phosphorylation
(GO:0016310)
|
epidermal growth factor receptor
(PR:000006933)
|
941: Activation, EGFR
|
| 821 |
increased |
synaptic transmission, glutamatergic
(GO:0035249)
|
|
None
|
| 822 |
increased |
synaptic transmission, glutamatergic
(GO:0035249)
|
glutamate(1-)
(CHEBI:14321)
|
None
|